Bita Esmaeli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bita Esmaeli has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
J. Matthew Debnam
Department of Neuroradiology, The University of Texas M.D. Anderson Cancer Center
3 shared publications- James Matthew Debnam
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
2 shared publications Agni Kakouri
Department of Ophthalmology, University of Texas McGovern School of Medicine, Houston, TX, USA
1 shared publication- Amy Catherine Moreno
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication Bradley A. Thuro
Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA
1 shared publicationCésar Fernández
Oculoplastics Clinic, Department of Ophthalmology, Hospital Universitario Universidad Autónoma de Nuevo León
1 shared publication
Latest Publications
- 24 September 2026
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 66 (4) , 18-26
Surgical Management of Lacrimal Gland Tumors
Epithelial lacrimal gland tumors are rare but important to diagnose early. The initial surgical decision to do an incisional biopsy versus gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Until recently, orbital exenteration was considered the standard surgical approach for malignant epithelial tumors of the lacrimal gland. However, more recently, eye-sparing surgical resection followed by radiation therapy has gained popularity in selected patients. In this manuscript, we will review the typical clinical and radiologic features of pleomorphic adenoma of the lacrimal gland compared with those of lacrimal gland carcinoma, and we will review published data regarding local control and survival for malignant lacrimal gland tumors with eye-sparing surgery and radiation.
- 24 September 2026
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 66 (4) , 18-26
Surgical Management of Lacrimal Gland Tumors
Epithelial lacrimal gland tumors are rare but important to diagnose early. The initial surgical decision to do an incisional biopsy versus gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Until recently, orbital exenteration was considered the standard surgical approach for malignant epithelial tumors of the lacrimal gland. However, more recently, eye-sparing surgical resection followed by radiation therapy has gained popularity in selected patients. In this manuscript, we will review the typical clinical and radiologic features of pleomorphic adenoma of the lacrimal gland compared with those of lacrimal gland carcinoma, and we will review published data regarding local control and survival for malignant lacrimal gland tumors with eye-sparing surgery and radiation.
- Open Access
Clinical and Radiologic Features Correlated with Eye-Sparing Surgery vs. Orbital Exenteration for Lacrimal Gland Adenoid Cystic Carcinoma
Background: To determine if certain clinical and radiologic features of lacrimal gland adenoid cystic carcinoma (LGACC) on pre-operative MRI were associated with the treatment decision to perform orbital exenteration versus eye-sparing surgery. Methods: All consecutive patients with LGACC treated by orbital exenteration (Group 1) versus eye-sparing surgery (Group 2) from June 2007 to March 2024 were identified through a search of the primary author’s patient database. Data analyzed included patient demographics, T category at presentation (using AJCC 8th edition criteria), and magnetic resonance imaging (MRI) features, including T1 post-contrast enhancement patterns and T2 signal characteristics. The MRIs were reviewed by a CAQ-certified neuroradiologist. The location of the LGACC—including the distance of the posterior tumor margin from the superior orbital fissure (SOF), bone remodeling and destruction, involvement of the extra-ocular muscles (EOMs), temporal fossa, pterygopalatine fossa, sinonasal cavity, intracranial compartment, and the presence of perineural tumor spread—were analyzed. Results: The study included a total of 39 patients. A total of 16 patients with a median age of 52.6 years were in Group 1, and 23 patients with a median age of 46.1 years were in Group 2. A greater T-category and larger size of the tumor were significantly more common in Group 1. Smooth tumor margins were significantly more common in Group 2, while irregular margins were significantly more common in Group 1. The distance from the posterior tumor margin to the SOF was significantly less in Group 1. Crossing the vertical midline of the orbit, bone destruction, and the invasion of the EOMs were significantly more common in Group 1. Extension to involve the cavernous sinus, pterygopalatine foramen, and sinonasal cavity, as well as perineural spread, were only present in Group 1. No significant difference was noted between T1 post-contrast patterns and T2 characteristics. Conclusions: MRI features of LGACC more commonly associated with orbital exenteration as opposed to eye-sparing surgery included larger size and irregular margins, as well as the posterior tumor margin being closer to the SOF, crossing the vertical midline of the orbit, bone destruction, and the involvement of the EOMS, cavernous sinus, pterygopalatine foramen, and sinonasal cavity. These MRI features may aid oculoplastic surgeons in determining which patients may be candidates for successful eye-sparing surgery for the treatment of LGACC.
Open AccessClinical and Radiologic Features Correlated with Eye-Sparing Surgery vs. Orbital Exenteration for Lacrimal Gland Adenoid Cystic Carcinoma
Background: To determine if certain clinical and radiologic features of lacrimal gland adenoid cystic carcinoma (LGACC) on pre-operative MRI were associated with the treatment decision to perform orbital exenteration versus eye-sparing surgery. Methods: All consecutive patients with LGACC treated by orbital exenteration (Group 1) versus eye-sparing surgery (Group 2) from June 2007 to March 2024 were identified through a search of the primary author’s patient database. Data analyzed included patient demographics, T category at presentation (using AJCC 8th edition criteria), and magnetic resonance imaging (MRI) features, including T1 post-contrast enhancement patterns and T2 signal characteristics. The MRIs were reviewed by a CAQ-certified neuroradiologist. The location of the LGACC—including the distance of the posterior tumor margin from the superior orbital fissure (SOF), bone remodeling and destruction, involvement of the extra-ocular muscles (EOMs), temporal fossa, pterygopalatine fossa, sinonasal cavity, intracranial compartment, and the presence of perineural tumor spread—were analyzed. Results: The study included a total of 39 patients. A total of 16 patients with a median age of 52.6 years were in Group 1, and 23 patients with a median age of 46.1 years were in Group 2. A greater T-category and larger size of the tumor were significantly more common in Group 1. Smooth tumor margins were significantly more common in Group 2, while irregular margins were significantly more common in Group 1. The distance from the posterior tumor margin to the SOF was significantly less in Group 1. Crossing the vertical midline of the orbit, bone destruction, and the invasion of the EOMs were significantly more common in Group 1. Extension to involve the cavernous sinus, pterygopalatine foramen, and sinonasal cavity, as well as perineural spread, were only present in Group 1. No significant difference was noted between T1 post-contrast patterns and T2 characteristics. Conclusions: MRI features of LGACC more commonly associated with orbital exenteration as opposed to eye-sparing surgery included larger size and irregular margins, as well as the posterior tumor margin being closer to the SOF, crossing the vertical midline of the orbit, bone destruction, and the involvement of the EOMS, cavernous sinus, pterygopalatine foramen, and sinonasal cavity. These MRI features may aid oculoplastic surgeons in determining which patients may be candidates for successful eye-sparing surgery for the treatment of LGACC.
- Open Access
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1852743
Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland and impact on initial surgical planning
Precis: Approximately one-quarter of lacrimal gland masses present with imaging findings not consistent with standard teaching for benign vs. malignant; it is prudent to do gross total resection in such cases if eye-sparing surgery is possible. Background: Epithelial lacrimal gland tumors are rare. The initial surgical decision to do an incisional biopsy vs. gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Occasionally, the reported radiologic features attributed to benign vs. malignant lacrimal gland tumors do not hold. In this report, we will focus on these atypical presentations to help the orbital surgeon with better surgical planning. Methods: Epithelial lacrimal gland tumors diagnosed in 101 consecutive patients (59 adenoid cystic carcinomas, 24 other carcinomas, and 18 pleomorphic adenomas) and treated by the primary author were included. The clinical and radiologic records were retrospectively reviewed. The clinical parameters analyzed included age, gender, histologic type, and surgical treatment. The radiologic data analyzed included radiologic characteristics of the lacrimal gland mass on the initial magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation. Cases that did not follow the “standard” imaging characteristics of carcinoma or pleomorphic adenoma were further analyzed. Results: Overall, two possible atypical radiologic patterns were identified: (1) 11 of 59 (19%) cases of adenoid cystic carcinoma and 5 of 24 (21%) cases of other carcinomas were identified where the lesion was round and well-circumscribed, lacked a posterior extension or other aggressive features, and could not be distinguished from pleomorphic adenoma but after surgical resection were found to be adenoid cystic carcinoma or other types of lacrimal gland carcinoma; (2) 5 of 18 (28%) cases of pleomorphic adenoma presented with large multilobular masses and could not be distinguished from a carcinoma but in fact were found to be of benign nature on histologic evaluation. Conclusions: Our findings suggest some overlap in radiologic features between pleomorphic adenomas and lacrimal gland carcinomas. Given the risk of multifocal benign or malignant recurrence of pleomorphic adenomas if excised incompletely, it seems prudent to err on the side of gross total resection for most well-circumscribed lesions of the lacrimal gland that lack aggressive radiologic features. Some of these well-circumscribed lesions will end up being adenoid cystic carcinoma or other types of lacrimal gland carcinomas upon pathologic evaluation of the surgical specimen and may require additional treatments.
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1852743
Open AccessAtypical imaging characteristics in patients with epithelial tumors of lacrimal gland and impact on initial surgical planning
Precis: Approximately one-quarter of lacrimal gland masses present with imaging findings not consistent with standard teaching for benign vs. malignant; it is prudent to do gross total resection in such cases if eye-sparing surgery is possible. Background: Epithelial lacrimal gland tumors are rare. The initial surgical decision to do an incisional biopsy vs. gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Occasionally, the reported radiologic features attributed to benign vs. malignant lacrimal gland tumors do not hold. In this report, we will focus on these atypical presentations to help the orbital surgeon with better surgical planning. Methods: Epithelial lacrimal gland tumors diagnosed in 101 consecutive patients (59 adenoid cystic carcinomas, 24 other carcinomas, and 18 pleomorphic adenomas) and treated by the primary author were included. The clinical and radiologic records were retrospectively reviewed. The clinical parameters analyzed included age, gender, histologic type, and surgical treatment. The radiologic data analyzed included radiologic characteristics of the lacrimal gland mass on the initial magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation. Cases that did not follow the “standard” imaging characteristics of carcinoma or pleomorphic adenoma were further analyzed. Results: Overall, two possible atypical radiologic patterns were identified: (1) 11 of 59 (19%) cases of adenoid cystic carcinoma and 5 of 24 (21%) cases of other carcinomas were identified where the lesion was round and well-circumscribed, lacked a posterior extension or other aggressive features, and could not be distinguished from pleomorphic adenoma but after surgical resection were found to be adenoid cystic carcinoma or other types of lacrimal gland carcinoma; (2) 5 of 18 (28%) cases of pleomorphic adenoma presented with large multilobular masses and could not be distinguished from a carcinoma but in fact were found to be of benign nature on histologic evaluation. Conclusions: Our findings suggest some overlap in radiologic features between pleomorphic adenomas and lacrimal gland carcinomas. Given the risk of multifocal benign or malignant recurrence of pleomorphic adenomas if excised incompletely, it seems prudent to err on the side of gross total resection for most well-circumscribed lesions of the lacrimal gland that lack aggressive radiologic features. Some of these well-circumscribed lesions will end up being adenoid cystic carcinoma or other types of lacrimal gland carcinomas upon pathologic evaluation of the surgical specimen and may require additional treatments.
- Open Access
- 15 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 359
Excessive Tearing and Lacrimal and Canalicular Blockage Secondary to Docetaxel in Breast Cancer Patients in the Metastatic and Adjuvant Settings
While most ophthalmologists and medical oncologists are aware of the excessive tearing and canalicular and lacrimal duct blockage associated with docetaxel, there is lack of deeper understanding of the appropriate management of this side effect and what clinical settings justify surgical intervention as opposed to conservative management. In this review, we summarize the findings in the seminal original research studies that document the association between the frequency of administration of docetaxel and treatment duration and the frequency of excessive tearing as a subjective symptom versus canalicular and lacrimal duct blockage as anatomic findings seen during probing and irrigation. Based on the published literature to date, we note that excessive tearing is a common and important side effect of docetaxel and can be seen in breast cancer patients who are receiving docetaxel either weekly or every three weeks in metastatic or adjuvant settings. However, the anatomic findings of canalicular and lacrimal duct stenosis are almost exclusively seen in patients receiving weekly docetaxel or in patients with metastatic breast cancer who are treated with docetaxel for prolonged periods. Lacrimal duct blockage is much less commonly reported in patients with early breast cancer who are receiving docetaxel every three weeks for short durations and, to our knowledge to date, have not been reported in the literature in breast cancer patients receiving docetaxel in the adjuvant setting.
- 15 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 359
Open AccessExcessive Tearing and Lacrimal and Canalicular Blockage Secondary to Docetaxel in Breast Cancer Patients in the Metastatic and Adjuvant Settings
While most ophthalmologists and medical oncologists are aware of the excessive tearing and canalicular and lacrimal duct blockage associated with docetaxel, there is lack of deeper understanding of the appropriate management of this side effect and what clinical settings justify surgical intervention as opposed to conservative management. In this review, we summarize the findings in the seminal original research studies that document the association between the frequency of administration of docetaxel and treatment duration and the frequency of excessive tearing as a subjective symptom versus canalicular and lacrimal duct blockage as anatomic findings seen during probing and irrigation. Based on the published literature to date, we note that excessive tearing is a common and important side effect of docetaxel and can be seen in breast cancer patients who are receiving docetaxel either weekly or every three weeks in metastatic or adjuvant settings. However, the anatomic findings of canalicular and lacrimal duct stenosis are almost exclusively seen in patients receiving weekly docetaxel or in patients with metastatic breast cancer who are treated with docetaxel for prolonged periods. Lacrimal duct blockage is much less commonly reported in patients with early breast cancer who are receiving docetaxel every three weeks for short durations and, to our knowledge to date, have not been reported in the literature in breast cancer patients receiving docetaxel in the adjuvant setting.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Ophthalmology
- Vol. 6, 1822331
Application of imaging studies for orbital tumors: a practical review and representative cases
Orbital imaging has undergone a significant transformation over the past few decades, evolving from basic radiographic techniques to sophisticated cross-sectional imaging modalities. Historically, conventional radiography was limited to visualizing only the bony structures of the orbit or radiodense foreign bodies, making it inadequate for detecting soft tissue pathology. Advances in imaging over the last several decades—first with computed tomography (CT) in the 1970s and later with magnetic resonance imaging (MRI) in the 1980s—have revolutionized orbital diagnostics by enabling detailed visualization of both osseous and soft tissue structures. Magnetic resonance imaging (MRI) has emerged as the preferred modality for evaluating orbital tumors and other soft tissue lesions. Its superior soft tissue resolution, multiplanar imaging capability, and ability to characterize lesion morphology and extent make it crucial in clinical practice. MRI is especially valuable in differentiating benign from malignant lesions, evaluating involvement of critical structures such as the globe, optic nerve, extraocular muscles, and vascular components, and assessing disease at the orbital apex or with suspected intracranial extension. Advanced MRI techniques, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI, further enhance diagnostic accuracy. In pediatric populations, MRI holds particular importance due to its lack of ionizing radiation and its effectiveness. In contrast, while CT offers superior resolution of bony anatomy and is useful for detecting calcifications and fractures, it is somewhat limited in soft tissue differentiation and involves exposure to ionizing radiation. While CT examination can be tailored to evaluate bone or soft tissues, orbital CT is typically reserved for cases requiring detailed osseous assessment, acute trauma settings, or for patients who cannot undergo an MRI. MRI creates high-resolution images by detecting signals emitted by hydrogen nuclei when exposed to a strong magnetic field and radiofrequency pulses. Differences in signal based on tissue composition and water content are captured and converted into high-resolution images. Interpreting orbital lesions requires standardized terminology.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Ophthalmology
- Vol. 6, 1822331
Open AccessApplication of imaging studies for orbital tumors: a practical review and representative cases
Orbital imaging has undergone a significant transformation over the past few decades, evolving from basic radiographic techniques to sophisticated cross-sectional imaging modalities. Historically, conventional radiography was limited to visualizing only the bony structures of the orbit or radiodense foreign bodies, making it inadequate for detecting soft tissue pathology. Advances in imaging over the last several decades—first with computed tomography (CT) in the 1970s and later with magnetic resonance imaging (MRI) in the 1980s—have revolutionized orbital diagnostics by enabling detailed visualization of both osseous and soft tissue structures. Magnetic resonance imaging (MRI) has emerged as the preferred modality for evaluating orbital tumors and other soft tissue lesions. Its superior soft tissue resolution, multiplanar imaging capability, and ability to characterize lesion morphology and extent make it crucial in clinical practice. MRI is especially valuable in differentiating benign from malignant lesions, evaluating involvement of critical structures such as the globe, optic nerve, extraocular muscles, and vascular components, and assessing disease at the orbital apex or with suspected intracranial extension. Advanced MRI techniques, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI, further enhance diagnostic accuracy. In pediatric populations, MRI holds particular importance due to its lack of ionizing radiation and its effectiveness. In contrast, while CT offers superior resolution of bony anatomy and is useful for detecting calcifications and fractures, it is somewhat limited in soft tissue differentiation and involves exposure to ionizing radiation. While CT examination can be tailored to evaluate bone or soft tissues, orbital CT is typically reserved for cases requiring detailed osseous assessment, acute trauma settings, or for patients who cannot undergo an MRI. MRI creates high-resolution images by detecting signals emitted by hydrogen nuclei when exposed to a strong magnetic field and radiofrequency pulses. Differences in signal based on tissue composition and water content are captured and converted into high-resolution images. Interpreting orbital lesions requires standardized terminology.
- 10 April 2026
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 623-630
Anatomy of the Visual Pathways
- 10 April 2026
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 623-630
Anatomy of the Visual Pathways
- 1 April 2026
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 761-774
Orbital Tumors
- 1 April 2026
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 761-774
Orbital Tumors
- Open Access
- 15 March 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (5)
Response to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland
- 15 March 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (5)
Open AccessResponse to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland
- 28 October 2025
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 751-759
Multidisciplinary Management of Tumors of the Orbit
- 28 October 2025
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 64 (4) , 751-759
Multidisciplinary Management of Tumors of the Orbit